Highlights for the Three Months Ended November 30, 2025 — Total revenues of $236 million and net income of $31 million — 22% increase in lease rental revenue compared to third quarter 2024 — Adjusted EBITDA(1) of $221 million — Acquired 9 aircraft for $355 million; fiscal year-to-date aircraft acquisitions of $1.3 billion with a […]

This segment aired on Advancements on Saturday, December 13th via Bloomberg Television. A recent episode of Advancements with Ted Danson focused on innovations in proven Behavioral/Cognitive Science theory and Adaptive Learning. As broadcast on Advancements on December 13, 2025, this segment explores how artificial intelligence is forcing business leaders to rethink the way they approach

Hamilton Lane Incorporated (Nasdaq: HLNE) is scheduled to release financial results for the third fiscal quarter ended December 31, 2025 before the market opens on Tuesday, February 3, 2026. A copy of the earnings release and full detailed presentation will be available on the Hamilton Lane Shareholders website at https://shareholders.hamiltonlane.com/. Hamilton Lane will host a

Tetrous, Inc., a Sherman Oaks start up focused on bone-to-tendon healing following orthopedic surgery, announced today that a sixth patent (U.S. Patent Number 12,502,459) related to the EnFix family of demineralized cortical bone fiber implants and their method of manufacture has been issued by the United States Patent and Trademark Office. The newly issued patent

The latest version of NFPA LiNK introduces powerful new tools and an AI assistant, helping professionals apply safety standards with confidence and speed The National Fire Protection Association® (NFPA®) today announced a major milestone update to its digital platform NFPA LiNK®, which provides access to the organization’s vast codes and standards library and other related

On average, the fastest-growing cardiology reprocessing company has received one FDA clearance every 10 weeks for the past 10 years. Innovative Health, Inc. today announced that the company has received its 50th clearance from FDA to reprocess single-use medical devices used in electrophysiology and cardiology labs. This latest clearance is to reprocess the Agilis NxT

New Crypto Mutuum Finance (MUTM) Reports Presale Activity as Phase 7 Momentum Builds GlobeNewswire January 13, 2026 DUBAI, United Arab Emirates, Jan. 13, 2026 (GLOBE NEWSWIRE) — The first months of 2026 have produced a renewed interest in early-stage cryptocurrencies tied to real protocol deployment. Among the new entrants gaining attention is Mutuum Finance (MUTM).

Sono-Tek Reports Fiscal Third Quarter and Nine-Month Fiscal 2026 Financial Results GlobeNewswire January 13, 2026 Seventh Consecutive Quarter of Revenue Over $5 Million Driven by Continued Strength in Medical Market and High-ASP Production Systems Gross Margin Expands to 50% in the Quarter and 51% Year-to-Date Third Quarter and Nine-Month Net Income Increased 24% and 32%

Ocugen to Host Webcast on Thursday, January 15 at 8:30 a.m. ET to Discuss OCU410 Phase 2 Clinical Trial Data GlobeNewswire January 13, 2026 MALVERN, Pa., Jan. 13, 2026 (GLOBE NEWSWIRE) — Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that it will

Energous Reports Preliminary Financial Results for Fiscal Year 2025, Marking a Transformational Year of Growth and Platform Expansion GlobeNewswire January 13, 2026 Energous reports preliminary revenue of approximately $5.6 million for the year ended December 31, 2025, representing more than 630% year-over-year growth and record annual revenue. For the quarter ended December 31, 2025, Energous